The European Patent Office (EPO) has approved a restricted patent on the Harvard OncoMouse, dealing a setback to activists who fought for 9 years to bar EU patents on living organisms. The EPO on July ...

That would be the Oncomouse, an animal that made scientific and legal history as the first transgenic mammal to be the subject of a United States patent. The Oncomouse, engineered for the express ...

The 'Harvard OncoMouse' patent (EP 0,169,672) has been further restricted, after several organizations appealed a March 2003 European Patent Office (EPO) decision to allow the patent to apply to ...